Trials / Completed
CompletedNCT00273481
Cosopt Versus Xalacom
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 33 (planned)
- Sponsor
- Pharmaceutical Research Network · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To compare the intraocular pressure efficacy and safety of the DTFC given twice daily versus the LTFC given once every morning following a run-in period with timolol maleate given twice daily.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | dorzolamide 2%/timolol maleate 0.5% fixed combination | |
| DRUG | latanoprost 0.005%/timolol maleate 0.5% fixed combination | |
| DRUG | timolol maleate 0.5% | |
| DRUG | placebo |
Timeline
- Start date
- 2005-09-01
- Completion
- 2007-04-01
- First posted
- 2006-01-09
- Last updated
- 2008-11-19
Locations
2 sites across 2 countries: Canada, Slovenia
Source: ClinicalTrials.gov record NCT00273481. Inclusion in this directory is not an endorsement.